News

Investigators say children with cortical/cerebral visual impairment experience markedly lower vision-specific quality of life

Study results indicate that maintaining control of blood pressure and hemoglobin A1c are key to preventing the onset of diabetic retinopathy

This study also investigated the development of myopia rebound when dosing was discontinued

Susana Chung, OD, PhD, speaks about one of her ARVO presentations and the future of artificial intelligence in eye care

Study data demonstrated a significant correlation between visual function, structure and neurological impairment in an experimental autoimmune encephalomyelitis model

Ahead of the meeting, several companies previewed product pipeline announcements and research data presentations

The meeting kicks off with symposia and an opening keynote speech from Ed Yong

During the month of May, Prevent Blindness will offer fact sheets, videos and other resources for IRD education

Gildeuretinol halts Stargardt disease progression, study results indicate

The online tool shows vision loss simulations for diabetic macular oedema, diabetic retinopathy, age-related macular degeneration and other retinal diseases

Prof Tadayoni was a much-admired leader, researcher, surgeon and EURETINA President

The tissue serves as a testing ground for outpatient ocular therapies

The 15th annual Congress on Controversies in Ophthalmology heads to Athens, Greece

Lohith Shetty will lead marketing for the company, based in Kleinostheim, Germany

I-SCREEN will bring together 12 institutions across Europe, including Queen’s University Belfast

Investigators presented research on the pre-treatment outcomes during the 2024 ASCRS meeting

Lourens van Zyl wanted to set himself apart in a highly competitive surrounding and saw a potential for practice building by offering solutions for presbyopia in patients without cataract. Within a few years this group became a significant segment of his practice in total share. ZEISS PRESBYOND was the game changer for a business success story.

Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation

Three IOLs are evaluated in a randomised study

Multimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages

The UK's Royal National Institute of Blind People is the global distributor of the headset and ARxVision is partnering with the National Federation of the Blind and Vision Australia to expand global accessibility

Investigators analysed the incidence and mortality rates from conjunctival melanoma cases over a 32-year period

An AI-supported telemedicine effort from Siloam Vision and Orbis International

In addition to the primary safety and tolerability endpoints, the study also saw signals of biological response from EXN407

The opportunities and challenges presented by CRISPR manipulation

The European Commission is expected to make a decision about the application before the end of June